2000 Frontis Plaza Blvd.
Suite 250
Winston-Salem, NC 27103
United States
336 999 7028
https://www.prokidney.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 163
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Bruce Culleton M.D. | CEO & Director | 657,93k | N/A | 1968 |
Dr. Timothy A. Bertram D.V.M., Ph.D. | Founder | 1,46M | N/A | 1955 |
Mr. Todd C. Girolamo Esq., J.D., M.B.A. | Chief Legal Officer & Secretary | 541,59k | N/A | 1965 |
Ms. Mary Weger | Chief People Officer | N/A | N/A | 1959 |
Dr. Joseph M. Stavas M.D., M.P.H. | Senior VP of Interventional Procedures & Patient Safety | N/A | N/A | N/A |
Dr. Darin J. Weber Ph.D. | Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access | N/A | N/A | 1968 |
Mr. Nikhil L. Pereira-Kamath | Chief Business Officer | N/A | N/A | N/A |
Mr. Richard Williams | Senior Vice President of Information Technology | N/A | N/A | N/A |
Dr. Aparna Sahoo M.D. | VP & Head of Global Clinical Development | N/A | N/A | N/A |
Emily Butler Ph.D. | Senior VP of Biometric | N/A | N/A | N/A |
ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.
ProKidney Corp.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 8. Die grundlegenden Scores sind Audit: 10, Vorstand: 7, Shareholderrechte: 4, Kompensation: 7.